Abiopharma

🔍 Williamson Douglas J (Executive)

Company: Vistagen Therapeutics, Inc. (VTGN)

Report Date: 2026-07-29

Detailed Transactions and Holdings:

• Acquired 40,826 shares of Stock Options (Right to Buy) at $0.2433 per share (Derivative)
  Date: 2026-07-29 | Code: A | Expires: 2036-07-29 | equity_swap_involved: 0 | shares_owned_after: 40,826.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents stock options granted in connection with the reporting person's appointment to the Issuer's Board of Directors. The stock options were granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, and vest in three equal annual installments, beginning on the first anniversary of the date of the grant.